Some experts in the medical field are asking the government to deregulate buprenorphine, an addiction treatment drug, arguing that requiring providers to take an eight-hour X-waiver training course before administering the drug and submitting to subsequent audits by the Drug Enforcement Administration (DEA) has limited its availability in the medical community amid the opioid epidemic.
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
Please enter your username or email address. You will receive a link to create a new password via email.
Get New Password
Please enter your email. You'll receive an email with your one-time use Snappy Login Link™. Just click the link within 30 minutes to automatically login.
Get Snappy Login Link™